More rare experience orphan drug launches patient relationships


There’s something to be said for experience, and we’ve got a lot of it. Since 1999, Siren has been paving the way in the rare disease space. We’ve helped clients make their first social media forays, and we’ve launched more orphan drugs than any other marketing agency.

Check out our clients with whom we’ve worked with on more than 30 different disease states over the years.

Our clients are
redefining healthcare

Tackling the needs of the rare disease community is a tall order, but our clients are up to the task. As a company that is passionately focused on orphan drug marketing, we share a common vision with the companies with whom we work.

  • Baxter
  • QOL Medical
  • Biomarin
  • Lundbeck
  • Medtronic
  • Recordati Rare Diseases
  • NPS Pharmaceuticals
  • GlaxoSmithKline
  • Endo Pharmaceuticals
  • Novo Nordisk
  • Abbott
  • Communispace
  • Patients Like Me
  • Aegerion Pharmaceuticals
  • Vidara Therapeutics
  • Genzyme

Leading the charge against
7,000 rare diseases

Every disorder should have a treatment, no matter how rare or how complex it is. From hemophilia to Huntington’s disease to hypoparathyroidism, we’re taking rare diseases on head to head. For more than 15 years, across more than 30 disease states we’ve had 1 focus—rare disease marketing.

Rare Opportunities Platform™

Our central hub of rare disease information, the Rare Opportunities Platform™ contains data on a wide range of rare disorders. Using the database, we can survey the landscape of a given disease state, from available treatment options to relevant patient organizations and more. When we have a comprehensive understanding of the disease state, we then perform predictive analysis to determine which marketing tactics are most likely to meet the needs of the patient community and meet our client’s goals for success.

Cardiovascular Severe familial hypercholesterolemia Endocrinological Hypoparathyroidism Acromegaly Gastrointestinal Short bowel syndrome Congenital sucrase-isomaltase deficiency Exocrine pancreatic insufficiency Hematological Hemophilia A Hemophilia B Anti-inhibitor coagulant complex Factor VII deficiency Acute intermittent porphyria Protein C deficiency Hypovolemia/Hypoalbuminemia Immunological Primary immunodeficiency Chronic granulomatous disease Immune thrombocytopenia Wiskott-Aldrich syndrome (WAS) Common variable immunodeficiency (CVID) Metabolic Morquio syndrome (MPS IVA) Type 1 diabetes Musculoskeletal Duchenne muscular dystrophy (DMD) Neurological Huntington’s disease Leukodystrophies Oncological Bladder cancer Breast cancer Essential thrombocytopenia Myelofibrosis Polycythemia vera Pulmonological Alpha-1 antitrypsin deficiency Idiopathic pulmonary fibrosis
all we do is rare